JILLIAN MERTZ: Open Payments
NPI 1578338018 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,303 in 35 payments from 7 companies in 2025. Trend: 2023 $184 · 2024 $703 · 2025 $1,303
Food & beverage: $1,303
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 12 | $437 |
| Medtronic, Inc. | 16 | $423 |
| Edwards Lifesciences Corporation | 1 | $211 |
| Novo Nordisk Inc | 1 | $111 |
| Novartis Pharmaceuticals Corporation | 3 | $56 |
| CARDIVA MEDICAL, INC. | 1 | $37 |
| Kestra Medical Technology Services, Inc. | 1 | $28 |
Products named: SYMPLICITY G3, FARAPULSE, WATCHMAN FLX, Ozempic, General - Therapies, LEQVIO, COREVALVE EVOLUT R, CARDIVA VASCADE MVP VVCS 6-12F.
Industry payments across PA — which companies pay providers there.
